|
| | Linagliptin Impurity H Basic information |
| Product Name: | Linagliptin Impurity H | | Synonyms: | Linagliptin Impurity H;1-((4-methylquinazolin-2-yl)methyl)piperidin-3-amine;Linagliptin impurity 12/7-(2-Butyn-1-yl)-8-(dimethylamino)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;Linagliptin Imp.K;1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-8-(dimethylamino)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;Linagliptin H;7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione;7-(But-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (Linagliptin Impurity) | | CAS: | 1646355-34-1 | | MF: | C22H23N7O2 | | MW: | 417.46 | | EINECS: | | | Product Categories: | | | Mol File: | 1646355-34-1.mol |  |
| | Linagliptin Impurity H Chemical Properties |
| Boiling point | 583.0±60.0 °C(Predicted) | | density | 1.30±0.1 g/cm3(Predicted) | | pka | 2.47±0.50(Predicted) |
| | Linagliptin Impurity H Usage And Synthesis |
| Uses | 7-(But-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione is an impurity of Linagliptin (L465900), a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. |
| | Linagliptin Impurity H Preparation Products And Raw materials |
|
